https://www.heparegenix.com/news/heparegenix-raises-e15-million-series-c-round-to-advance-clinical-development-of-hrx-215-for-liver-regeneration/
HepaRegeniX raises €15 million Series C round to advance clinical development of HRX-215 for liver...
Mar 31, 2025 - Tuebingen (Germany), July 10, 2024 – HepaRegeniX GmbH, a clinical stage company developing a novel regenerative therapy for the treatment of acute and chronic…